Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Safety and Efficacy Study of NGGT002 in PKU Adult Subjects [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating the safety and efficacy of NGGT002 in adults with phenylketonuria is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NGGT002

Snippet

Sponsor: The First Affiliated Hospital of Bengbu Medical University | Conditions: Phenylketonurias | EARLY_Phase 1 | Status: RECRUITING